Financial statements Wpd Pharmaceuticals
Balance sheet data of WPD PHARMACEUTICALS
|
Year
|
2017
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 685 053,17 | 1 614 255,22 | 3 499 857,80 | 16 028 151,67 | 13 506 782,36 | 16 914 203,18 |
| A. Fixed assets | 340 983,73 | 257 351,83 | 807 181,78 | 138 732,70 | 187 969,39 | 190 883,38 |
| B. Current assets | 344 069,44 | 1 356 903,39 | 2 692 676,02 | 15 889 418,97 | 13 318 812,97 | 16 723 319,80 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 685 053,17 | 1 614 255,22 | 3 499 857,80 | 16 028 151,67 | 13 506 782,36 | 16 914 203,18 |
| A. Equity | -2 602 874,60 | -2 056 420,56 | -3 518 191,61 | -7 624 890,28 | -3 355 231,65 | 6 751 100,04 |
| B. Liabilities and provisions for liabilities | 3 287 927,77 | 3 670 675,78 | 7 018 049,41 | 23 653 041,95 | 16 862 014,01 | 10 163 103,14 |
| I. Long-term liabilities | 296 112,20 | 0,00 | 0,00 | 8 910 904,06 | 0,00 | 0,00 |
| II. Short-term liabilities | 2 991 815,57 | 3 670 675,78 | 7 018 049,41 | 5 396 430,30 | 8 325 744,94 | 1 176 959,78 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.